Advanced Pharmaceutical Bulletin; eISSN 2251-7308 2014
DOI: 10.5681/apb.2014.048
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Formulation Variables and Storage Conditions on Light Protected Vitamin B12 Mixed Parenteral Formulations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 15 publications
0
6
0
1
Order By: Relevance
“…Thus, CNCbl contents remained at >95% of the labeled claim after 12 months of storage at room temperature in all three single-ingredient preparations, whereas its contents decreased to 28-37% of the labeled claim in the four multi-ingredient preparations [151]. CNCbl degradation in commercial parenteral preparations containing thiamine and pyridoxine, after two months of their light-protected storage at 40 • C, was additionally confirmed by Monajjemzadeh et al By evaluating the CNCbl stability after 5 days at 55 • C in experimentally prepared parenteral formulations containing different CNCbl, thiamine, and pyridoxine combinations, they confirmed the CNCbl stability in a single-ingredient CNCbl solution as well as in combination with pyridoxine (97%) and its degradation in solutions with thiamine (79%) and especially in combination with thiamine and pyridoxine (41%) [150]. Recently, there is an increasing number of studies that highlight the photolability of MeCbl in liquid dosage forms and the need for its light-protected storage and proper stabilization [212][213][214].…”
Section: Vitamin B 12 Stability In Foodsmentioning
confidence: 54%
See 2 more Smart Citations
“…Thus, CNCbl contents remained at >95% of the labeled claim after 12 months of storage at room temperature in all three single-ingredient preparations, whereas its contents decreased to 28-37% of the labeled claim in the four multi-ingredient preparations [151]. CNCbl degradation in commercial parenteral preparations containing thiamine and pyridoxine, after two months of their light-protected storage at 40 • C, was additionally confirmed by Monajjemzadeh et al By evaluating the CNCbl stability after 5 days at 55 • C in experimentally prepared parenteral formulations containing different CNCbl, thiamine, and pyridoxine combinations, they confirmed the CNCbl stability in a single-ingredient CNCbl solution as well as in combination with pyridoxine (97%) and its degradation in solutions with thiamine (79%) and especially in combination with thiamine and pyridoxine (41%) [150]. Recently, there is an increasing number of studies that highlight the photolability of MeCbl in liquid dosage forms and the need for its light-protected storage and proper stabilization [212][213][214].…”
Section: Vitamin B 12 Stability In Foodsmentioning
confidence: 54%
“…As reported above, Bajaj and Singhal evaluated CNCbl degradation kinetics at less extreme pH values (2, 4, 6, 8, and 10) at three temperatures (4, 25, and 37 • C) with the highest degradation extent and rate at pH 2 and lowest at pH 6 [142]. Other papers report the highest CNCbl stability in different pH ranges: 4-7 [3,117], 4-6.5 [150], 4.5-5 [151], and 4-4.5 [131]. The official requirements for the pH of CNCbl solutions are 4.0-5.0 for CNCbl oral solution in the British Pharmacopeia [152], and 4.5-7.0 for CNCbl injections in the United States Pharmacopeia [153].…”
Section: Ph Of the Solutionmentioning
confidence: 92%
See 1 more Smart Citation
“…4 [57]. Physical and chemical factors such as light, heat, moisture, oxidizing and reducing agents, acids and bases all impact the stability of vitamin B negatively [58]. A study on fortification of freeze-dried meals demonstrated that this method would be a significantly fruitful means of improving the quality of military pack meals that addresses shortfalls in vitamin B levels [59].…”
Section: Vitamin Bmentioning
confidence: 99%
“…Es posible administrar las vitaminas B neurotrópicas para el tratamiento de la neuropatía periférica de forma combinada por vía oral, sin embargo, es importante tener presente que debe evitarse su administración conjunta por vía parenteral debido a incompatibilidad farmacéutica entre la vitamina B12 y los otros componentes de la formulación (141). Además, la vitamina B12 es altamente fotosensible, con el consecuente riesgo de degradación de la molécula (142).…”
Section: Consideraciones Farmacéuticasunclassified